ROYAL BANK OF CANADA - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 50 filers reported holding OCUPHIRE PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$52,000
-44.1%
15,405
-28.0%
0.00%
Q2 2023$93,00021,405
+428000.0%
0.00%
Q1 2023$050.0%0.00%
Q4 2022$050.0%0.00%
Q3 2022$050.0%0.00%
Q2 2022$050.0%0.00%
Q1 2022$050.0%0.00%
Q4 2021$050.0%0.00%
Q3 2021$050.0%0.00%
Q2 2021$050.0%0.00%
Q1 2021$050.0%0.00%
Q4 2020$050.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 340,526$1,276,9762.16%
Knoll Capital Management, LLC 100,000$375,0000.58%
RICE HALL JAMES & ASSOCIATES, LLC 809,117$3,034,1890.17%
Diametric Capital, LP 55,648$208,6800.10%
MAI Capital Management 494,690$1,855,0880.03%
TRUST CO OF TOLEDO NA /OH/ 26,000$97,5000.02%
Bedel Financial Consulting, Inc. 15,000$56,2500.01%
Legato Capital Management LLC 16,456$61,7100.01%
OCCUDO QUANTITATIVE STRATEGIES LP 19,623$73,5860.01%
Cornerstone Capital, Inc. 16,357$61,3390.01%
View complete list of OCUPHIRE PHARMA INC shareholders